Melinta Therapeutics has entered into a restructuring support agreement with the lenders pursuant to a pre-negotiated chapter 11 plan of reorganization.
“We are confident that this process will secure new ownership of the business with the financial resources to support the Company’s antibiotics portfolio and ensure these potentially life-saving products continue to get to patients in need,” said Jennifer Sanfilippo, interim chief executive officer. more